(Q41667366)

6 October 2017

1 reference

title

Nucleic acid-based antiviral and gene therapy of chronic hepatitis B infection (English)

1 reference

6 October 2017

0 references

1 reference

Wands JR

1

1 reference

6 October 2017

Geissler M

2

1 reference

6 October 2017

Putlitz JZ

3

1 reference

6 October 2017

Blum H

4

1 reference

6 October 2017

von Weizsäcker F

5

1 reference

6 October 2017

Mohr L

6

1 reference

6 October 2017

Yoon SK

7

1 reference

6 October 2017

Melegari M

8

1 reference

6 October 2017

Scaglioni PP

9

1 reference

6 October 2017

language of work or name

1 reference

1 October 1997

1 reference

Journal of Gastroenterology and Hepatology

6 October 2017

1 reference

6 October 2017

12

1 reference

6 October 2017

9-10

1 reference

6 October 2017

S354-69

1 reference

Inhibition of vesicular stomatitis virus protein synthesis and infection by sequence-specific oligodeoxyribonucleoside methylphosphonates

6 October 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00521.X

Antiviral effect of an oligo(nucleoside methylphosphonate) complementary to the splice junction of herpes simplex virus type 1 immediate early pre-mRNAs 4 and 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00521.X

Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00521.X

Inhibition of replication and expression of human T-cell lymphotropic virus type III in cultured cells by exogenous synthetic oligonucleotides complementary to viral RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00521.X

Selective inhibition of the cytopathic effect of type A influenza viruses by oligodeoxynucleotides covalently linked to an intercalating agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00521.X

Antisense oligodeoxynucleotide phosphorothioate complementary to Gag mRNA blocks replication of human immunodeficiency virus type 1 in human peripheral blood cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00521.X

Inhibition of hepatitis B virus by antisense oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00521.X

The chemistry of self-splicing RNA and RNA enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00521.X

Simple RNA enzymes with new and highly specific endoribonuclease activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00521.X

Sequence requirements of the hammerhead RNA self-cleavage reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00521.X

Design of RNA enzymes distinguishing a single base mutation in RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00521.X

Ribozymes as potential anti-HIV-1 therapeutic agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00521.X

Biochemical and genetic evidence for the hepatitis B virus replication strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00521.X

Cleavage of hepatitis B virus RNA by three ribozymes transcribed from a single DNA template

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00521.X

HIV-1 Gag mutants can dominantly interfere with the replication of the wild-type virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00521.X

Stable expression of transdominant Rev protein in human T cells inhibits human immunodeficiency virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00521.X

Gene therapy. Intracellular immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00521.X

Characterization of hepatitis B virus core mutants that inhibit viral replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00521.X

Potential mechanism for sustained antiretroviral efficacy of AZT-3TC combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00521.X

Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00521.X

Hepatitis B virus immunopathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00521.X

Genetic immunization is a simple method for eliciting an immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00521.X

Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00521.X

Preclinical efficacy of a prototype DNA vaccine: Enhanced protection against antigenic drift in influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00521.X

Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00521.X

Gene inoculation generates immune responses against human immunodeficiency virus type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00521.X

Helminth infection results in decreased virus-specific CD8+ cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00521.X

Interleukin 12 suppresses autoantibody production by reversing helper T-cell phenotype in hepatitis B e antigen transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00521.X

Hepatitis B synthetic immunogen comprised of nucleocapsid T-cell sites and an envelope B-cell epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00521.X

Inhibition of human immunodeficiency virus in early infected and chronically infected cells by antisense oligodeoxynucleotides and their phosphorothioate analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00521.X

Inhibition of human immunodeficiency virus replication by antisense oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00521.X

Tissue-specific targeting of retroviral vectors through ligand-receptor interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00521.X

Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00521.X

Implications of ribozyme kinetics for targeting the cleavage of specific RNA molecules in vivo: more isn't always better

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00521.X

Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00521.X

Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00521.X

Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00521.X

21 January 2018

The hepatitis B virus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00521.X

10.1111/J.1440-1746.1997.TB00521.X

21 January 2018

Identifiers

DOI

1 reference

6 October 2017

1 reference